Mutational analysis of DAX1 in patients with hypogonadotropic hypogonadism or pubertal delay

John C. Achermann, Wen Xia Gu, Tom J. Kotlar, Joshua J. Meeks, Leah P. Sabacan, Stephanie B. Seminara, Reema L. Habiby, Peter C. Hindmarsh, David P. Bick, Richard J. Sherins, William F. Crowley, Lawrence C Layman, J. Larry Jameson

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

Although delayed puberty is relatively common and often familial, its molecular and pathophysiologic basis is poorly understood. In contrast, the molecular mechanisms underlying some forms of hypogonadotropic hypogonadism (HH) are clearer, following the description of mutations in the genes KAL, GNRHR, and PROP1. Mutations in another gene, DAX1 (AHC), cause X-linked adrenal hypoplasia congenita and HH. Affected boys usually present with primary adrenal failure in infancy or childhood and HH at the expected time of puberty. DAX1 mutations have also been reported to occur with a wider spectrum of clinical presentations. These cases include female carriers of DAX1 mutations with marked pubertal delay and a male with incomplete HH and mild adrenal insufficiency in adulthood. Given this emerging phenotypic spectrum of clinical presentation in men and women with DAX1 mutations, we hypothesized that DAX1 might be a candidate gene for mutation in patients with idiopathic sporadic or familial HH or constitutional delay of puberty. Direct sequencing of DAX1 was performed in 106 patients, including 85 (80 men and 5 women) with sporadic HH or constitutional delay of puberty and patients from 21 kindreds with familial forms of these disorders. No DAX1 mutations were found in these groups of patients, although silent single nucleotide polymorphisms were identified (T114C, G498A). This study suggests that mutations in DAX1 are unlikely to be a common cause of HH or pubertal delay in the absence of a concomitant history of adrenal insufficiency.

Original languageEnglish (US)
Pages (from-to)4497-4500
Number of pages4
JournalJournal of Clinical Endocrinology and Metabolism
Volume84
Issue number12
DOIs
StatePublished - Jan 1 1999

Fingerprint

Hypogonadism
Genes
Mutation
Puberty
Polymorphism
Adrenal Insufficiency
Nucleotides
Delayed Puberty
Single Nucleotide Polymorphism

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Achermann, J. C., Gu, W. X., Kotlar, T. J., Meeks, J. J., Sabacan, L. P., Seminara, S. B., ... Jameson, J. L. (1999). Mutational analysis of DAX1 in patients with hypogonadotropic hypogonadism or pubertal delay. Journal of Clinical Endocrinology and Metabolism, 84(12), 4497-4500. https://doi.org/10.1210/jc.84.12.4497

Mutational analysis of DAX1 in patients with hypogonadotropic hypogonadism or pubertal delay. / Achermann, John C.; Gu, Wen Xia; Kotlar, Tom J.; Meeks, Joshua J.; Sabacan, Leah P.; Seminara, Stephanie B.; Habiby, Reema L.; Hindmarsh, Peter C.; Bick, David P.; Sherins, Richard J.; Crowley, William F.; Layman, Lawrence C; Jameson, J. Larry.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 84, No. 12, 01.01.1999, p. 4497-4500.

Research output: Contribution to journalArticle

Achermann, JC, Gu, WX, Kotlar, TJ, Meeks, JJ, Sabacan, LP, Seminara, SB, Habiby, RL, Hindmarsh, PC, Bick, DP, Sherins, RJ, Crowley, WF, Layman, LC & Jameson, JL 1999, 'Mutational analysis of DAX1 in patients with hypogonadotropic hypogonadism or pubertal delay', Journal of Clinical Endocrinology and Metabolism, vol. 84, no. 12, pp. 4497-4500. https://doi.org/10.1210/jc.84.12.4497
Achermann, John C. ; Gu, Wen Xia ; Kotlar, Tom J. ; Meeks, Joshua J. ; Sabacan, Leah P. ; Seminara, Stephanie B. ; Habiby, Reema L. ; Hindmarsh, Peter C. ; Bick, David P. ; Sherins, Richard J. ; Crowley, William F. ; Layman, Lawrence C ; Jameson, J. Larry. / Mutational analysis of DAX1 in patients with hypogonadotropic hypogonadism or pubertal delay. In: Journal of Clinical Endocrinology and Metabolism. 1999 ; Vol. 84, No. 12. pp. 4497-4500.
@article{34f40cdf214740c09c2fafb266a904a2,
title = "Mutational analysis of DAX1 in patients with hypogonadotropic hypogonadism or pubertal delay",
abstract = "Although delayed puberty is relatively common and often familial, its molecular and pathophysiologic basis is poorly understood. In contrast, the molecular mechanisms underlying some forms of hypogonadotropic hypogonadism (HH) are clearer, following the description of mutations in the genes KAL, GNRHR, and PROP1. Mutations in another gene, DAX1 (AHC), cause X-linked adrenal hypoplasia congenita and HH. Affected boys usually present with primary adrenal failure in infancy or childhood and HH at the expected time of puberty. DAX1 mutations have also been reported to occur with a wider spectrum of clinical presentations. These cases include female carriers of DAX1 mutations with marked pubertal delay and a male with incomplete HH and mild adrenal insufficiency in adulthood. Given this emerging phenotypic spectrum of clinical presentation in men and women with DAX1 mutations, we hypothesized that DAX1 might be a candidate gene for mutation in patients with idiopathic sporadic or familial HH or constitutional delay of puberty. Direct sequencing of DAX1 was performed in 106 patients, including 85 (80 men and 5 women) with sporadic HH or constitutional delay of puberty and patients from 21 kindreds with familial forms of these disorders. No DAX1 mutations were found in these groups of patients, although silent single nucleotide polymorphisms were identified (T114C, G498A). This study suggests that mutations in DAX1 are unlikely to be a common cause of HH or pubertal delay in the absence of a concomitant history of adrenal insufficiency.",
author = "Achermann, {John C.} and Gu, {Wen Xia} and Kotlar, {Tom J.} and Meeks, {Joshua J.} and Sabacan, {Leah P.} and Seminara, {Stephanie B.} and Habiby, {Reema L.} and Hindmarsh, {Peter C.} and Bick, {David P.} and Sherins, {Richard J.} and Crowley, {William F.} and Layman, {Lawrence C} and Jameson, {J. Larry}",
year = "1999",
month = "1",
day = "1",
doi = "10.1210/jc.84.12.4497",
language = "English (US)",
volume = "84",
pages = "4497--4500",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "12",

}

TY - JOUR

T1 - Mutational analysis of DAX1 in patients with hypogonadotropic hypogonadism or pubertal delay

AU - Achermann, John C.

AU - Gu, Wen Xia

AU - Kotlar, Tom J.

AU - Meeks, Joshua J.

AU - Sabacan, Leah P.

AU - Seminara, Stephanie B.

AU - Habiby, Reema L.

AU - Hindmarsh, Peter C.

AU - Bick, David P.

AU - Sherins, Richard J.

AU - Crowley, William F.

AU - Layman, Lawrence C

AU - Jameson, J. Larry

PY - 1999/1/1

Y1 - 1999/1/1

N2 - Although delayed puberty is relatively common and often familial, its molecular and pathophysiologic basis is poorly understood. In contrast, the molecular mechanisms underlying some forms of hypogonadotropic hypogonadism (HH) are clearer, following the description of mutations in the genes KAL, GNRHR, and PROP1. Mutations in another gene, DAX1 (AHC), cause X-linked adrenal hypoplasia congenita and HH. Affected boys usually present with primary adrenal failure in infancy or childhood and HH at the expected time of puberty. DAX1 mutations have also been reported to occur with a wider spectrum of clinical presentations. These cases include female carriers of DAX1 mutations with marked pubertal delay and a male with incomplete HH and mild adrenal insufficiency in adulthood. Given this emerging phenotypic spectrum of clinical presentation in men and women with DAX1 mutations, we hypothesized that DAX1 might be a candidate gene for mutation in patients with idiopathic sporadic or familial HH or constitutional delay of puberty. Direct sequencing of DAX1 was performed in 106 patients, including 85 (80 men and 5 women) with sporadic HH or constitutional delay of puberty and patients from 21 kindreds with familial forms of these disorders. No DAX1 mutations were found in these groups of patients, although silent single nucleotide polymorphisms were identified (T114C, G498A). This study suggests that mutations in DAX1 are unlikely to be a common cause of HH or pubertal delay in the absence of a concomitant history of adrenal insufficiency.

AB - Although delayed puberty is relatively common and often familial, its molecular and pathophysiologic basis is poorly understood. In contrast, the molecular mechanisms underlying some forms of hypogonadotropic hypogonadism (HH) are clearer, following the description of mutations in the genes KAL, GNRHR, and PROP1. Mutations in another gene, DAX1 (AHC), cause X-linked adrenal hypoplasia congenita and HH. Affected boys usually present with primary adrenal failure in infancy or childhood and HH at the expected time of puberty. DAX1 mutations have also been reported to occur with a wider spectrum of clinical presentations. These cases include female carriers of DAX1 mutations with marked pubertal delay and a male with incomplete HH and mild adrenal insufficiency in adulthood. Given this emerging phenotypic spectrum of clinical presentation in men and women with DAX1 mutations, we hypothesized that DAX1 might be a candidate gene for mutation in patients with idiopathic sporadic or familial HH or constitutional delay of puberty. Direct sequencing of DAX1 was performed in 106 patients, including 85 (80 men and 5 women) with sporadic HH or constitutional delay of puberty and patients from 21 kindreds with familial forms of these disorders. No DAX1 mutations were found in these groups of patients, although silent single nucleotide polymorphisms were identified (T114C, G498A). This study suggests that mutations in DAX1 are unlikely to be a common cause of HH or pubertal delay in the absence of a concomitant history of adrenal insufficiency.

UR - http://www.scopus.com/inward/record.url?scp=0033305636&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033305636&partnerID=8YFLogxK

U2 - 10.1210/jc.84.12.4497

DO - 10.1210/jc.84.12.4497

M3 - Article

C2 - 10599708

AN - SCOPUS:0033305636

VL - 84

SP - 4497

EP - 4500

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 12

ER -